目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug category
1.2.2. Route of administration
1.2.3. Application
1.3. Regional scope
1.4. Estimates and forecasts timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased database
1.6.2. GVR’s internal database
1.6.3. Secondary sources
1.6.4. Primary research
1.6.5. Details of primary research
1.6.5.1. Data for primary interviews in North America
1.6.5.2. Data for primary interviews in Europe
1.6.5.3. Data for primary interviews in Asia Pacific
1.6.5.4. Data for primary interviews in Latin America
1.6.5.5. Data for Primary interviews in MEA
1.7. Information or Data Analysis
1.7.1. Data analysis models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.2. Approach 1: Commodity flow approach
1.9.3. Volume price analysis (Model 2)
1.9.4. Approach 2: Volume price analysis
1.10. List of Secondary Sources
1.11. List of Primary Sources
1.12. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Anticoagulants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Technological advancements in development of anticoagulant products
3.2.1.3. Growing adoption of Novel Oral Anticoagulants (NOACs)
3.2.1.4. Rising geriatric population and increase prevalence of obesity
3.2.2. Market restraint analysis
3.2.2.1. High price associated with Novel Oral Anticoagulants (NOACs)
3.2.2.2. Stringent government regulations and poor demand in underdeveloped countries
3.3. Anticoagulants Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Anticoagulants Market: Drug Category Estimates & Trend Analysis
4.1. Drug Category Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Anticoagulants Market by Drug Category Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Novel oral anticoagulants (NOACs)
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Eliquis
4.4.1.3. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Xarelto
4.4.1.5. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Savaysa & Lixiana
4.4.1.7. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.8. Pradaxa
4.4.1.9. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Heparin and Low Molecular Weight Heparin (LMWH)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Vitamin k Antagonist
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Direct thrombin inhibitors
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Anticoagulants Market: Route of Administration Estimates & Trend Anlysis
5.1. Route of Administration Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Anticoagulants Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Oral anticoagulants
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Injectable anticoagulants
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Anticoagulants Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Anticoagulants Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Atrial Fibrillation/Myocardial Infarction (Heart Attack)
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Deep Vein Thrombosis (DVT)
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Pulmonary Embolism
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Anticoagulants Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Aspen Holdings
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Bristol-Myers Squibb Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. GSK plc
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Sanofi
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Bayer AG
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Boehringer Ingelheim International GmbH
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. DAIICHI SANKYO COMPANY, LIMITED
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Johnson & Johnson Services, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Eisai Co., Ltd.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America anticoagulants market, by region, 2018 - 2030 (USD Million)
Table 3 North America anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 4 North America anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 5 North America anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 7 U.S. anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 8 U.S. anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 9 Canada anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 10 Canada anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 11 Canada anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 12 Europe anticoagulants market, by region, 2018 - 2030 (USD Million)
Table 13 Europe anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 14 Europe anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Europe anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 16 Germany anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 17 Germany anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 18 Germany anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 19 UK anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 20 UK anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 21 UK anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 22 France anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 23 France anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 24 France anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 25 Italy anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 26 Italy anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 27 Italy anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 28 Spain anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 29 Spain anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 30 Spain anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 32 Denmark anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 33 Denmark anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 35 Sweden anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 36 Sweden anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 37 Norway anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 38 Norway anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 39 Norway anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific anticoagulants market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 42 Asia Pacific anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 44 China anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 45 China anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 46 China anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 47 Japan anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 48 Japan anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 49 Japan anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 50 India anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 51 India anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 52 India anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 53 South Korea anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 54 South Korea anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 55 South Korea anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 56 Australia anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 57 Australia anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 58 Australia anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 59 Thailand anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 60 Thailand anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Thailand anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 63 Latin America anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 64 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 66 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 69 Brazil anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 70 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 74 Mexico anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 75 Mexico anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 76 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 77 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 78 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 79 Mexico anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 80 Argentina anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 81 Argentina anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 82 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 83 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 84 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 85 Argentina anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 86 MEA anticoagulants market, by region, 2018 - 2030 (USD Million)
Table 87 MEA anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 88 MEA anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 89 MEA anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 90 South Africa anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 91 South Africa anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 92 South Africa anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 96 UAE anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 97 UAE anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 98 UAE anticoagulants market, by application, 2018 - 2030 (USD Million)
Table 99 Kuwait anticoagulants market, by drug category, 2018 - 2030 (USD Million)
Table 100 Kuwait anticoagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 101 Kuwait anticoagulants market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Anticoagulants market: market outlook
Fig. 14 Anticoagulants competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Anticoagulants market driver impact
Fig. 20 Anticoagulants market restraint impact
Fig. 21 Anticoagulants market strategic initiatives analysis
Fig. 22 Anticoagulants market: Drug category movement analysis
Fig. 23 Anticoagulants market: Drug category outlook and key takeaways
Fig. 24 Novel oral anticoagulants (NOACs) market estimates and forecast, 2018 - 2030
Fig. 25 Heparin and Low Molecular Weight Heparin (LMWH) estimates and forecast, 2018 - 2030
Fig. 26 Vitamin k Antagonist market estimates and forecast, 2018 - 2030
Fig. 27 Direct thrombin inhibitors estimates and forecast, 2018 - 2030
Fig. 28 Others estimates and forecast, 2018 - 2030
Fig. 29 Anticoagulants Market: Route of administration movement Analysis
Fig. 30 Anticoagulants market: Route of administration outlook and key takeaways
Fig. 31 Oral anticoagulants market estimates and forecasts, 2018 - 2030
Fig. 32 Injectable anticoagulants market estimates and forecasts,2018 - 2030
Fig. 33 Anticoagulants market: Application movement analysis
Fig. 34 Anticoagulants market: Application outlook and key takeaways
Fig. 35 Atrial fibrillation/myocardial infarction (heart attack) market estimates and forecasts, 2018 - 2030
Fig. 36 Deep Vein Thrombosis (DVT) market estimates and forecasts,2018 - 2030
Fig. 37 Pulmonary embolism market estimates and forecasts, 2018 - 2030
Fig. 38 Other market estimates and forecasts,2018 - 2030
Fig. 39 Global anticoagulants market: Regional movement analysis
Fig. 40 Global anticoagulants market: Regional outlook and key takeaways
Fig. 41 Global anticoagulants market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America
Fig. 54 North America market estimates and forecasts, 2018 - 2030
Fig. 55 U.S. key country dynamics
Fig. 56 U.S. market estimates and forecasts, 2018 - 2030
Fig. 57 Canada key country dynamics
Fig. 58 Canada market estimates and forecasts, 2018 - 2030
Fig. 59 Europe
Fig. 60 Europe market estimates and forecasts, 2018 - 2030
Fig. 61 UK key country dynamics
Fig. 62 UK market estimates and forecasts, 2018 - 2030
Fig. 63 Germany key country dynamics
Fig. 64 Germany market estimates and forecasts, 2018 - 2030
Fig. 65 France key country dynamics
Fig. 66 France market estimates and forecasts, 2018 - 2030
Fig. 67 Italy key country dynamics
Fig. 68 Italy market estimates and forecasts, 2018 - 2030
Fig. 69 Spain key country dynamics
Fig. 70 Spain market estimates and forecasts, 2018 - 2030
Fig. 71 Denmark key country dynamics
Fig. 72 Denmark market estimates and forecasts, 2018 - 2030
Fig. 73 Sweden key country dynamics
Fig. 74 Sweden market estimates and forecasts, 2018 - 2030
Fig. 75 Norway key country dynamics
Fig. 76 Norway market estimates and forecasts, 2018 - 2030
Fig. 77 Asia Pacific
Fig. 78 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 79 China key country dynamics
Fig. 80 China market estimates and forecasts, 2018 - 2030
Fig. 81 Japan key country dynamics
Fig. 82 Japan market estimates and forecasts, 2018 - 2030
Fig. 83 India key country dynamics
Fig. 84 India market estimates and forecasts, 2018 - 2030
Fig. 85 Thailand key country dynamics
Fig. 86 Thailand market estimates and forecasts, 2018 - 2030
Fig. 87 South Korea key country dynamics
Fig. 88 South Korea market estimates and forecasts, 2018 - 2030
Fig. 89 Australia key country dynamics
Fig. 90 Australia market estimates and forecasts, 2018 - 2030
Fig. 91 Latin America
Fig. 92 Latin America market estimates and forecasts, 2018 - 2030
Fig. 93 Brazil key country dynamics
Fig. 94 Brazil market estimates and forecasts, 2018 - 2030
Fig. 95 Mexico key country dynamics
Fig. 96 Mexico market estimates and forecasts, 2018 - 2030
Fig. 97 Argentina key country dynamics
Fig. 98 Argentina market estimates and forecasts, 2018 - 2030
Fig. 99 Middle East and Africa
Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 101 South Africa key country dynamics
Fig. 102 South Africa market estimates and forecasts, 2018 - 2030
Fig. 103 Saudi Arabia key country dynamics
Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 105 UAE key country dynamics
Fig. 106 UAE market estimates and forecasts, 2018 - 2030
Fig. 107 Kuwait key country dynamics
Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 109 Market share of key market players- Anticoagulants market